While there is fear by many about the trend of hospitals consolidating into larger healthcare systems, one advantage...
Structural Heart
This structural heart channel includings content related to heart valve repair and replacement, left atrial appendage (LAA) occlusion, heart failure interventional device therapies, and occlusion of ASDs, VSDs and PFOs.
A CT scan assessment of the femoral access route challenges for a recent Central DuPage Hospital TAVR candidate. This image and the measurements were discussed by the heart team during its weekly meeting to determine if the TAVR delivery catheters could navigate the disease femoral artery and what options might best serve this patient.
Feature | Heart Valve Technology | April 20, 2018 | Dave Fornell
A transcaval access TAVR procedure, showing a guide wire in the vena cava and a snare located in the aorta to pull the guide wire through.
Feature | Heart Valve Technology | April 19, 2018 | Dave Fornell
Patient selection for who is best suited for a...
Videos | Heart Valve Technology | April 18, 2018
Northwestern Medicine has purchased several smaller Chicago suburban hospitals in the past few years to expand its...
News | Heart Valve Technology | April 06, 2018
April 6, 2018 — University Hospitals Harrington Heart & Vascular Institute has officially opened the APOLLO...
Technology | Structural Heart Occluders | April 03, 2018
April 3, 2018 — Following the unprecedented Gore REDUCE Clinical Study conclusion that closure of patent foramen...
Most of the big stories March 2018 were the late-breaking trial presentations at the American College of Cardiology (ACC) meeting during the month.
Feature | April 02, 2018 | Dave Fornell
Here is the list of the most popular articles and videos on the Diagnostic and Interventional Cardiology (DAIC)...
News | Heart Valve Technology | March 30, 2018
March 30, 2018 — LivaNova PLC announced the first patient enrollment in the Perceval Valve...
News | Heart Valve Technology | March 27, 2018
March 27, 2018 — Edwards Lifesciences Corp. announced that enrollment is complete in the...
A patient who received the HeartMate III LVAD system showing off his external battery pack. He served as a patient ambassador in the Abbott booth at ACC.18. The HeartMate III, with its magnetic levitated pump, showed a big reduction in clotting over previous LVADs in a key late-breaking trial at this year's conference.
Feature | ACC | March 27, 2018 | Dave Fornell
There were several notable presentations of new data on cardiovascular technologies at the recent 2018 American...
Edwards Lifesciences received European CE mark clearance for its self-expanding Centera transcatheter aortic valve replacement (TAVR) device for severe, symptomatic aortic stenosis patients at high risk of open-heart surgery. This was the top structural heart story of the month of February 2018.
Feature | March 20, 2018 | Dave Fornell
Here is the list of the most popular articles and videos on the Diagnostic and Interventional Cardiology (DAIC)...
News | ACC | March 20, 2018
March 20, 2018 — Among people with a type of hole in the heart, known as patent foramen ovale (PFO), those who...
Videos | Congenital Heart | March 20, 2018
A discussion with Ami Bhatt, M.D., director of the adult...
Videos | Heart Valve Technology | March 15, 2018
Insights from the STS/ACC TVT Transcatheter Valve Registry, presented at the American College of Cardiology (ACC)...
News | Heart Valve Technology | March 12, 2018
March 12, 2018 — Medtronic plc unveiled outcomes from the CoreValve U.S. Pivotal Extreme Risk Study and the real-...
News | Heart Valve Technology | March 07, 2018
The U.S. Food and Drug Administration expanded the approval of a...
